Fresenius Medical Care, a global leader in dialysis products and services, has dedicated its mission to enhancing patient quality of life through high-quality products, innovative technologies, and advanced treatment concepts. As of December 31, 2023, they served 332,000 patients across approximately 4,000 clinics worldwide. This extensive network is supported by around 40 production sites across all continents, ensuring the availability of dialysis machines, dialyzers, and related disposables. The company, with its corporate headquarters in Bad Homburg v. d. Höhe, Germany, also operates regional offices in Waltham, Massachusetts; Hong Kong; and Rio de Janeiro, Brazil.
With a focus on leveraging their deep expertise, Fresenius Medical Care aims to achieve sustainable and profitable growth while continually enhancing its services. By streamlining operations and eliminating redundancies, the company ensures a cohesive and comprehensive approach to patient care. Embracing diverse perspectives and maintaining a unified understanding of their goals, Fresenius Medical Care underscores their commitment to innovation and excellence. This strategy has solidified their role as a cornerstone in the global healthcare landscape, consolidating their competence and driving continuous improvement in the dialysis industry.
